Jerzy Sikora

Jerzy Sikora

Auto-generated profile, based on publicly available information

Jerzy Sikora

Department of Pregnancy Pathology, School of Health Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
ICIwona Czech
Iwona Czech
PFPiotr Fuchs
Piotr Fuchs
AFAnna Fuchs
Anna Fuchs
MLMiłosz Lorek
Miłosz Lorek
DTDominika Tobolska-Lorek
Dominika Tobolska-Lorek
JSJerzy Sikora
Jerzy Sikora
Background: To evaluate the effectiveness of pharmacological and non-pharmacological pain relief methods and to compare them. Materials and methods: 258 women were included in the study and interviewed using a questionnaire and the visual analogue scale for pain. They were divided into six groups depending on chosen method of labour pain relief: epidural anaesthesia (EA; n = 42), water immersion and water birth (WB; n = 40), nitrous oxide gas for pain control (G; n = 40), transcutaneous electrical nerve stimulation (TENS) (n = 50), multiple management (MM; n = 42), none (N; n = 44). Results: The average age of the women was 29.4 ± 3.74 years and 60.47% of them were nulliparous (n = 156). Mean values of labour pain intensity were 6.81 ± 2.26 during the first stage of labour; 7.86 ± 2.06 during the second stage, and 3.22 ± 2.46 during the third stage. There was no significant difference in pain level between epidural analgesia and gas groups in the first stage of labour (p = 0.74). Nevertheless, epidural analgesia reduced pain level during the second and third stage (both p < 0.01). The highest satisfaction level pertains to water immersion (n = 38; 95%). Conclusion: Epidural analgesia is the gold standard of labour pain relief, however water birth was found to be associated with the highest satisfaction level of the parturient women. The contentment of childbirth depends not only on the level of experienced pain, but also on the care provided to the parturient during pregnancy and labour.

1 October 2011 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
PSPiotr Skałba
Piotr Skałba
ACAnna Cygal
Anna Cygal
PMPawel Madej
Pawel Madej
ADAnna Dąbkowska-Huć
Anna Dąbkowska-Huć
JSJerzy Sikora
Jerzy Sikora
Magdalena Olszanecka-GlinianowiczMagdalena Olszanecka-Glinianowicz
Magdalena Olszanecka-Glinianowicz

AFAnna Fuchs
Anna Fuchs
ICIwona Czech
Iwona Czech
JSJerzy Sikora
Jerzy Sikora
PFPiotr Fuchs
Piotr Fuchs
MLMiłosz Lorek
Miłosz Lorek
Agnieszka Drosdzol-CopAgnieszka Drosdzol-Cop
Agnieszka Drosdzol-Cop
Sexual activity during pregnancy is determined by emotional, psychosocial, hormonal, and anatomical factors and varies during trimesters. This work aimed to establish women’s sexual activity during each trimester of pregnancy. A total of 624 women were included in the study and filled in the questionnaire three times, once during each trimester of pregnancy. The first part of the survey included questions about socio-demographic characteristics, obstetric history, and medical details of a given pregnancy. The second part was the Polish version of the female sexual function index (FSFI) questionnaire. Comparison of the mean scores for the overall sexual function of each trimester revealed clinically relevant sexual dysfunction in the second and third trimesters (mean values 25.9 ± 8.7 and 22.7 ± 8.7, respectively; p < 0.01). Women were most sexually active during their second trimester. In the first trimester of pregnancy, women were most likely to choose intercourse in the missionary position. Women with vocational education were characterized by the lowest and homogenous FSFI values. Total FSFI score depended on the martial status—the highest value pertained to married women (25.2 ± 6.9; p = 0.02).

1 November 2017 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
KWKatarzyna Wyskida
Katarzyna Wyskida
GFGrzegorz Franik
Grzegorz Franik
TWTomasz Wikarek
Tomasz Wikarek
Aleksander Jerzy OwczarekAleksander Jerzy Owczarek
Aleksander Jerzy Owczarek
ADAlham Delroba
Alham Delroba
Magdalena Olszanecka-GlinianowiczMagdalena Olszanecka-Glinianowicz
Magdalena Olszanecka-Glinianowicz
Context The aim of this study was to assess the plasma leptin, adiponectin, resistin, visfatin/NAMPT, omentin-1, vaspin, apelin, TNF-α, IL-6 and RBP4 levels in relation to hormonal changes during the menstrual cycle in young, healthy, normal-weight women. Methods The study involved 52 young, healthy, normal-weight women. Anthropometric parameters, body composition and levels of plasma leptin, adiponectin, resistin, visfatin/NAMPT, omentin-1, vaspin, apelin, TNF-α, IL-6 and RBP4 in addition to serum FSH, LH, estradiol, progesterone, 17-OH progesterone, androgens, SHBG and insulin concentrations were measured during a morning in fasting state three times: between days 2–4, days 12–14 and days 24–26 of the menstrual cycle. Results Plasma adiponectin, omentin-1, resistin and visfatin/NAMPT, apelin, TNF-α, IL-6 and RBP4 concentrations were stable during the menstrual cycle, while leptin and vaspin levels were significantly higher in both the midcycle and the luteal phases than those in the follicular phase. Multivariate regression analyses revealed that changes in leptin and vaspin levels between the follicular and the luteal phase are strongly related to changes in total testosterone levels. Conclusions Our results revealed stable levels of adipokines during the phases of the physiological menstrual cycle, except for leptin and vaspin, which showed increased levels in both the midcycle and the luteal phases. This effect was significantly associated with changes in the secretion of testosterone, 17-OH progesterone and insulin in the luteal phase.

1 May 2012 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
Magdalena Olszanecka-GlinianowiczMagdalena Olszanecka-Glinianowicz
Magdalena Olszanecka-Glinianowicz
PMPawel Madej
Pawel Madej
DZDariusz Zdun
Dariusz Zdun
MBMaria Bożentowicz-Wikarek
Maria Bożentowicz-Wikarek
JSJerzy Sikora
Jerzy Sikora
PSPiotr Skałba
Piotr Skałba

1 January 2014 in Ginekologia Polska
Verified
Journal Article
Open access
DKDanuta Kozłowska-Rup
Danuta Kozłowska-Rup
PCPiotr Czekaj
Piotr Czekaj
DPDanuta Plewka
Danuta Plewka
JSJerzy Sikora
Jerzy Sikora
ABC transporters, P-gp, MDR3, BCRP and MRP1, can bind both endo- and exogenous ligands. The latter include immunosuppressive, anticancer sedative, anticonvulsant, antiparasitic and cardiovascular drugs, as well as HIV protease inhibitors and antibiotics. Protein transporters are also involved in tissue distribution of orally administered medicines in combination therapy for gestational diabetes mellitus (GDM) and could be used during GDM treatment. The distribution depends on transporter specificity its expression and subcellular localization. The aim of the study was to compare P-gp, MDR3, BCRP and MRP1 localization in placental tissues from normal and GDM diabetic pregnancies. Tissue samples were taken from 10 normal and 10 GDM placentas. Immunohistochemical reactions were performed with the use of adequate monoclonal antibodies. Avidin-biotin-peroxidase complex method was used for the visualization of antigen-antibody complexes. P-gp, MDR3 and BCRP were found in all parts of normal human placenta i.e. the amniotic epithelium, cytotrophoblast, syncytiotrophoblast and decidual cells. P-gp and BCRP, but not MDR3 and MRP1, were also localized on the endothelial cells of fetal blood vessels in the chorionic plate, as well as stem and tertiary villi. MRP1 expression was observed in the cytotrophoblast and the syncytiotrophoblast. Its expression was very low or undetectable in the amniotic epithelium and the majority of decidual cells. Immunohistochemical reactions within the syncytiotrophoblast showed apical (P-gp, BCRP), apical and basal (MRP1) or diffuse (MDR3) distribution. The main changes observed in GDM placentas included weaker MRP1 and MDR3 positive reactions in the syncytiotrophoblast, slightly lower expression of P-gp in the decidual and amniotic epithelial cells, and MDR3 in the amniotic epithelium. Our results indicate that GDM-related changes in the environment of placental cells do not substantially influence tissue and subcellular location of ABC transporters. Nevertheless, the expression of P-gp, MDR3 and MRP1 may be lower in comparison to normal placentas. Basal syncytiotrophoblast transporters, MRP1 and MDR3, seem to be more sensitive to the influence of GDM than apical proteins, what may result in altered biodisposition of endogenous substrates and drugs.